Detalles de la búsqueda
1.
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
N Engl J Med
; 383(15): 1425-1435, 2020 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32966714
2.
Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: results from open-label extension.
Rheumatology (Oxford)
; 61(2): 617-627, 2022 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878154
3.
Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus.
Diabetes Obes Metab
; 22(4): 574-582, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31797522
4.
Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies.
Diabetes Obes Metab
; 22(12): 2276-2286, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32700421
5.
Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial.
Diabetes Obes Metab
; 21(4): 1027-1036, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30614616
6.
Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia.
Diabetes Obes Metab
; 21(6): 1474-1482, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30830724
7.
Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV).
Am Heart J
; 206: 11-23, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30290289
8.
Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET).
Diabetes Obes Metab
; 20(3): 520-529, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28857451
9.
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.
Diabetes Obes Metab
; 20(5): 1111-1120, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29266675
10.
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study.
Diabetes Obes Metab
; 20(3): 530-540, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28921862
11.
Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.
Rheumatology (Oxford)
; 55(11): 1946-1953, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27411482
12.
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.
Rheumatology (Oxford)
; 55(8): 1466-76, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114562
13.
The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects.
Cytokine
; 72(2): 197-203, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25661195
14.
Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.
Mov Disord
; 28(6): 817-20, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23589371
15.
Pharmacokinetics of different dosing strategies of oral posaconazole in patients with compromised gastrointestinal function and who are at high risk for invasive fungal infection.
Antimicrob Agents Chemother
; 56(5): 2652-8, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22290953
16.
Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial.
Anesth Analg
; 112(4): 804-12, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21385988
17.
Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV.
Diabetes Ther
; 12(4): 1175-1192, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33694093
18.
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab.
Inflamm Bowel Dis
; 27(12): 1963-1967, 2021 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33577644
19.
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis.
JAMA Cardiol
; 6(2): 148-158, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33031522
20.
Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials.
Diabetes Ther
; 11(6): 1347-1367, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32372382